Jazz Pharmaceuticals plc
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | $1.57B | $3.11B | $637.3M |
| FY2020 | $1.85B | $3.66B | $1.06B |
| FY2021 | $6.02B | $3.97B | $591.4M |
| FY2022 | $5.69B | $3.09B | $881.5M |
| FY2023 | $5.11B | $3.74B | $1.51B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | $1.57B | $3.11B | $637.3M |
| FY2020 | $1.85B | $3.66B | $1.06B |
| FY2021 | $6.02B | $3.97B | $591.4M |
| FY2022 | $5.69B | $3.09B | $881.5M |
| FY2023 | $5.11B | $3.74B | $1.51B |